OncoTarget, ‎1949-2553

Journal

Publications

  1. 2020
  2. Published

    Paradox breaker BRAF inhibitors have comparable potency and MAPK pathway reactivation to encorafenib in BRAF mutant colorectal cancer

    Oliver Pickles, , , Andrew Beggs & Gary Middleton, 25 Aug 2020, In: OncoTarget. 11, 34, p. 3188-3197 10 p.

    Research output: Contribution to journalArticlepeer-review

  3. 2019
  4. Published
  5. 2018
  6. Published

    MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome

    Rachel Bayley, & Paloma Garcia, 1 Dec 2018, In: OncoTarget. 9, 101, p. 37460-37461 2 p.

    Research output: Contribution to journalEditorialpeer-review

  7. Published
  8. Published
  9. Published
  10. Published
  11. 2017
  12. Published

    Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours

    Susanne Gatz & 4 others, , , & , 6 Dec 2017, In: OncoTarget. 8, 67, p. 112036-112050 15 p.

    Research output: Contribution to journalArticlepeer-review

  13. Published

    ULBPs: regulators of human lymphocyte stress recognition

    Jianmin Zuo, Benjamin Willcox & Paul Moss, 13 Nov 2017, In: OncoTarget.

    Research output: Contribution to journalEditorialpeer-review

  14. Published
  15. Published

    Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer.

    Yuk Ting Ma, Sarah Leonard, , Jen Anderton, , , & , 8 Sep 2017, In: OncoTarget. 8, 38, p. 63635–63645 11 p.

    Research output: Contribution to journalArticlepeer-review

  16. Published

    Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies

    Carmela De Santo & , 29 Jun 2017, In: OncoTarget. 8, 38, p. 63506-63517 12 p.

    Research output: Contribution to journalArticlepeer-review

  17. Published
  18. Published
  19. Published
  20. Published

    Differential regulation of cellular functions by the C-termini of transmembrane 4 L six family proteins in 2- or 3-dimensional environment.

    Fedor Berditchevski, 25 Jan 2017, In: OncoTarget. 8, 8, p. 13277-13292 16 p.

    Research output: Contribution to journalArticlepeer-review

  21. Published
  22. 2016
  23. Published

    Livin/BIRC7 expression as malignancy marker in adrenocortical tumors

    Cristina Ronchi, 21 Dec 2016, In: OncoTarget. 8, 6, p. 9323-9338 16 p.

    Research output: Contribution to journalArticlepeer-review

  24. Published
  25. Published

    CEACAM6 is upregulated by Helicobacter pylori CagA and is a biomarker for early gastric cancer

    & 2 others, & Neel Sharma, 11 Jul 2016, In: OncoTarget. 7, 34, p. 55290-55301 12 p.

    Research output: Contribution to journalArticlepeer-review

  26. Published

    Glutamate Receptor 2D is a novel angiogenic tumour endothelial marker in colorectal cancer

    Joseph Wragg, Stephen Ward, Victoria Heath, & Roy Bicknell, 12 May 2016, In: OncoTarget. 7, 15, p. 20440-20454

    Research output: Contribution to journalArticlepeer-review

  27. Published
  28. Published
  29. Published

    MicroRNA-708-5p acts as a therapeutic agent against metastatic lung cancer

    Lindsey Compton, & Zewei Luo, 19 Jan 2016, In: OncoTarget. 7, 3, p. 2417-32 16 p.

    Research output: Contribution to journalArticlepeer-review

  30. 2015
  31. Published

    Is lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?

    Geoff Brown & , 19 Oct 2015, In: OncoTarget. 6, 41, p. 43326-43341 16 p.

    Research output: Contribution to journalArticlepeer-review

  32. Published

    Development and characterisation of a 3D multi-cellular in vitro model of normal human breast: a tool for cancer initiation studies

    Vera Novitskaya, Fedor Berditchevski, & , 30 May 2015, In: OncoTarget. 6, 15, p. 13731-13741 11 p.

    Research output: Contribution to journalArticlepeer-review

  33. Published

    Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer

    Anthony Kong, 20 Mar 2015, In: OncoTarget. 6, 8, p. 5678-5694 17 p.

    Research output: Contribution to journalArticlepeer-review

  34. 2014
  35. Published

    Human PIF1 helicase supports DNA replication and cell growth under oncogenic-stress

    Eva Petermann, & , 5 Nov 2014, In: OncoTarget. 5, 22, p. 11381-11398 18 p.

    Research output: Contribution to journalArticlepeer-review

  36. Published

    ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer

    Anthony Kong, Aug 2014, In: OncoTarget. 5, 16, p. 6633-6646 14 p.

    Research output: Contribution to journalArticlepeer-review

  37. Published

    Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer

    Anthony Kong, 17 Apr 2014, In: OncoTarget. 5, 15, p. 5934-5949 16 p.

    Research output: Contribution to journalArticlepeer-review

  38. Published

    Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo

    Sarah Kuehne, & , 12 Jan 2014, In: OncoTarget. 5, 7, p. 1761-1769 9 p.

    Research output: Contribution to journalArticlepeer-review

  39. 2013
  40. Published

    Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer

    Anthony Kong, Oct 2013, In: OncoTarget. 4, 10, p. 1592-605 14 p.

    Research output: Contribution to journalArticlepeer-review

  41. 2012
  42. Published
  43. 2011
  44. Published